Laura Graham, MD
Medical Oncology
Board Certified
Care Philosophy
My approach to care centers on building a true partnership with each patient and family, grounded in clear and direct communication, compassion, and respect for individual goals and values. As a medical oncologist specializing in genitourinary cancers, I aim to provide evidence-based, personalized treatment while helping patients navigate complex decisions with confidence. I am deeply committed to advancing the field through clinical trials and translational research, with a focus on innovative therapies and understanding why treatments work for some patients and not others. By integrating cutting-edge science with attentive, whole-person care, I strive to offer patients access to the most promising options today while contributing to better treatments for the future. I am seeing patients with prostate cancer, testicular (germ cell) cancer, adrenal cortical cancer, bladder/urothelial cancer, kidney cancer, and rare genitourinary cancers.
Title(s)
Assistant Professor
Credentials
Doctor of Medicine
Specialty
Medical Oncology, Internal Medicine
Scheduling Phone Number
720-848-0170
Gender
Female
Hospital Affiliation
University of Colorado Hospital
Provider Information
Specialties
- Medical Oncology (2021)
- Internal Medicine (2018)
Conditions
-
Cancers
Kidney Cancer , Bladder Cancer , Testicular Cancer , Prostate Cancer , Urologic Cancer
Department
Assistant Professor, Medicine-Medical Oncology
Professional Memberships
American Society of Clinical Oncology (ASCO), Member
Research and Grants
Research Interests for Patients
My research focuses on developing more effective treatments for advanced prostate cancer and other genitourinary malignancies through innovative clinical trials and translational science. I am particularly interested in hormone-based therapies, immunotherapy combinations, and T-cell–directed approaches aimed at overcoming treatment resistance and improving durable responses. My work integrates patient care with laboratory investigation, including analyses of blood and tumor samples to better understand how therapies reshape the tumor immune microenvironment and to identify biomarkers that predict which patients are most likely to benefit. I collaborate closely with multidisciplinary academic teams, cooperative groups, and industry partners to accelerate the development of personalized therapies and to translate promising scientific discoveries into meaningful advances for patients with genitourinary cancers.
Education and Training
Medical Schools
MD, Rush Medical College of Rush University Medical Center (2015)
Undergraduate Schools
BA, University of Chicago (IL) (2009)
Residency Program
University of Washington Program (2018)
Fellowships
University of Washington Program (2021)
Information for referring providers
Referral Contact Phone
720-848-0170